BMI View: The Hungarian healthcare sector will continue to face challenges which will limit the country’s
attractiveness to multinational pharmaceutical firms. Low wages, a rising disease burden and the migrant
crisis have caused the healthcare system to be labelled as in a critical condition.
Headline Expenditure Projections
? Pharmaceuticals: HUF660.80bn (USD2.37bn) in 2015 to HUF668.00bn (USD2.28bn) in 2016; +1.1%
in local currency terms and -3.5% in US dollar terms. Forecast revised downwards from last quarter.
? Healthcare: HUF2.43trn (USD8.70bn) in 2015 to HUF2.47trn (USD8.43bn) in 2016; +1.6% in local
currency terms and -3.1% in US dollar terms. Forecast revised downwards from last quarter.

Table of Contents

BMI Industry View 7
Table: Headline Pharmaceuticals & Healthcare Forecasts (Hungary 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Hungary 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Hungary 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Hungary 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Hungary 2012-2020) 17
Prescription Drug Market 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Hungary 2012-2020) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Hungary 2012-2020) 22
Generic Drug Market Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Hungary 2012-2020) 24
OTC Medicine Market Forecast 25
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Hungary 2012-2020) 26
Pharmaceutical Trade Forecast 27
Table: Pharmaceutical Trade Data And Forecasts (Hungary 2014-2020) 28
Table: Pharmaceutical Trade Data And Forecasts local currency (Hungary 2014-2020) 29
Industry Risk Reward Index 30
Central And Eastern Europe Risk/Reward Index 30
Hungary Risk/Reward Index 36
Rewards 36
Risks 36
Regulatory Review 38
Intellectual Property Issues 40
Pricing Regime 41
Table: OEP Reimbursement Changes, September 2014 43
Reimbursement Regime 43
Market Overview 46
Healthcare Sector 47
Table: Healthcare Resources (Hungary 2010-2015) 48
Table: Healthcare Personnel (Hungary 2010-2015) 49
Table: Healthcare Activity (Hungary 2010-2015) 49
Research & Development 50
Clinical Trials 51
Epidemiology 52
Competitive Landscape 55
Research-Based Industry 55
Table: Multinational Market Activity 57
Generic Drugmakers 58
Pharmaceutical Distribution 59
Pharmaceutical Retail Sector 60
Company Profile 62
Egis Pharmaceuticals (Servier) 62
Gedeon Richter 65
Demographic Forecast 70
Table: Population Headline Indicators (Hungary 1990-2025) 71
Table: Key Population Ratios (Hungary 1990-2025) 71
Table: Urban/Rural Population & Life Expectancy (Hungary 1990-2025) 72
Table: Population By Age Group (Hungary 1990-2025) 72
Table: Population By Age Group % (Hungary 1990-2025) 73
Glossary 75
Methodology 77
Pharmaceutical Expenditure Forecast Model 77
Healthcare Expenditure Forecast Model 77
Notes On Methodology 78
Risk/Reward Index Methodology 79
Index Overview 80
Table: Pharmaceutical Risk/Reward Index Indicators 80
Indicator Weightings 81

List of Tables

Table: Headline Pharmaceuticals & Healthcare Forecasts (Hungary 2014-2020)
Table: Pharmaceutical Sales, Historical Data And Forecasts (Hungary 2012-2020)
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Hungary 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Hungary 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Hungary 2012-2020)
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Hungary 2012-2020)
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Hungary 2012-2020)
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Hungary 2012-2020)
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Hungary 2012-2020)
Table: Pharmaceutical Trade Data And Forecasts (Hungary 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Hungary 2014-2020)
Table: OEP Reimbursement Changes, September 2014
Table: Healthcare Resources (Hungary 2010-2015)
Table: Healthcare Personnel (Hungary 2010-2015)
Table: Healthcare Activity (Hungary 2010-2015)
Table: Multinational Market Activity
Table: Population Headline Indicators (Hungary 1990-2025)
Table: Key Population Ratios (Hungary 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Hungary 1990-2025)
Table: Population By Age Group (Hungary 1990-2025)
Table: Population By Age Group % (Hungary 1990-2025)
Table: Pharmaceutical Risk/Reward Index Indicators